{
    "title": "Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions",
    "abstract": "Background Squamous cell carcinoma is the most common form of malignancy of the oral cavity, and is often proceeded by oral potentially malignant disorders (OPMD). Early detection of oral cavity squamous cell carcinoma (oral cancer) can improve survival rates. The current diagnostic standard of surgical biopsy with histology is painful for patients and involves a delay in order to process the tissue and render a histological diagnosis; other diagnostic tests are available that are less invasive and some are able to provide immediate results. This is an update of a Cochrane Review first published in 2015.    Objectives Primary objective: to estimate the diagnostic accuracy of index tests for the detection of oral cancer and OPMD, in people presenting with clinically evident suspicious and innocuous lesions.  Secondary objective: to estimate the relative accuracy of the different index tests.   Search methods Cochrane Oral Health's Information Specialist searched the following databases: MEDLINE Ovid (1946 to 20 October 2020), and Embase Ovid (1980 to 20 October 2020). The US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) and the World Health Organization International Clinical Trials Registry Platform were also searched for ongoing trials to 20 October 2020. No restrictions were placed on the language or date of publication when searching the electronic databases. We conducted citation searches, and screened reference lists of included studies for additional references.    Selection criteria We selected studies that reported the diagnostic test accuracy of the following index tests when used as an adjunct to conventional oral examination in detecting OPMD or oral cavity squamous cell carcinoma: vital staining (a dye to stain oral mucosa tissues), oral cytology, light\u2010based detection and oral spectroscopy, blood or saliva analysis (which test for the presence of biomarkers in blood or saliva).    Data collection and analysis Two review authors independently screened titles and abstracts for relevance. Eligibility, data extraction and quality assessment were carried out by at least two authors, independently and in duplicate. Studies were assessed for methodological quality using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS\u20102). Meta\u2010analysis was used to combine the results of studies for each index test using the bivariate approach to estimate the expected values of sensitivity and specificity.    Main results This update included 63 studies (79 datasets) published between 1980 and 2020 evaluating 7942 lesions for the quantitative meta\u2010analysis. These studies evaluated the diagnostic accuracy of conventional oral examination with: vital staining (22 datasets), oral cytology (24 datasets), light\u2010based detection or oral spectroscopy (24 datasets). Nine datasets assessed two combined index tests. There were no eligible diagnostic accuracy studies evaluating blood or salivary sample analysis. Two studies were classed as being at low risk of bias across all domains, and 33 studies were at low concern for applicability across the three domains, where patient selection, the index test, and the reference standard used were generalisable across the population attending secondary care.  The summary estimates obtained from the meta\u2010analysis were:\u2010 vital staining: sensitivity 0.86 (95% confidence interval (CI) 0.79 to 0.90) specificity 0.68 (95% CI 0.58 to 0.77), 20 studies, sensitivity low\u2010certainty evidence, specificity very low\u2010certainty evidence;\u2010 oral cytology: sensitivity 0.90 (95% CI 0.82 to 0.94) specificity 0.94 (95% CI 0.88 to 0.97), 20 studies, sensitivity moderate\u2010certainty evidence, specificity moderate\u2010certainty evidence;\u2010 light\u2010based: sensitivity 0.87 (95% CI 0.78 to 0.93) specificity 0.50 (95% CI 0.32 to 0.68), 23 studies, sensitivity low\u2010certainty evidence, specificity very low\u2010certainty evidence; and\u2010 combined tests: sensitivity 0.78 (95% CI 0.45 to 0.94) specificity 0.71 (95% CI 0.53 to 0.84), 9 studies, sensitivity very low\u2010certainty evidence, specificity very low\u2010certainty evidence.    Authors' conclusions At present none of the adjunctive tests can be recommended as a replacement for the currently used standard of a surgical biopsy and histological assessment. Given the relatively high values of the summary estimates of sensitivity and specificity for oral cytology, this would appear to offer the most potential. Combined adjunctive tests involving cytology warrant further investigation. Potentially eligible studies of blood and salivary biomarkers were excluded from the review as they were of a case\u2010control design and therefore ineligible. In the absence of substantial improvement in the tests evaluated in this updated review, further research into biomarkers may be warranted.",
    "review_type": "Diagnostic",
    "doi": "https://doi.org/10.1002/14651858.CD010276.pub3",
    "review_id": "CD010276",
    "criteria": {
        "Types of studies": "Studies evaluating index test(s) that reported on the diagnostic accuracy for individuals presenting with clinically evident suspicious or innocuous lesions. The index tests assessed in this review are provided in Additional Table 1. Eligible study designs included cross\u2010sectional diagnostic test accuracy studies (or consecutive series) and randomised studies of diagnostic test accuracy. We excluded studies that collected data retrospectively, reported in abstract form alone, case\u2010control studies, uncontrolled reports and randomised controlled trials (RCTs) of the effectiveness of screening programmes (intervention studies).",
        "Participants": "Adults (aged 16 years or over) presenting to primary or secondary care with clinically evident suspicious or innocuous oral lesions. The clinical setting is important as studies enrolling patients referred to a specialist care evaluate index tests that are predominantly carried out by clinical experts in cohorts with a higher percentage of dysplastic or malignant lesions than would be expected in a general population.",
        "Index tests": "Index tests used alone, or in combination, as an adjunct to the conventional oral examination (COE) (Additional Table 1) by either primary care clinicians or secondary care specialists. If a study reported two or more tests then we included those tests in the analysis if it was reasonable to assume that the two tests were conducted or interpreted independently of each other. If this was not the case, then we used the results from the first test only. Where an index test was used as a combined test and reported the results as a single data point, then these were considered as a combination of tests and reported and analysed separately.",
        "Target conditions": "Following the consensus views of the expert working group of the World Health Organization (WHO) Collaborating Centre for Oral Cancer/Precancer (Warnakulasuriya 2007), the following were considered. Oral cancer. Oral cancer. Oral cavity squamous cell carcinoma (OSCC). Oral cavity squamous cell carcinoma (OSCC). Oral potentially malignant disorders (OPMD). Oral potentially malignant disorders (OPMD). Leukoplakia.   Proliferative verrucous leukoplakia.   Erythroplakia.   Lupus erythematosus.   Submucous fibrosis.   Hereditary disorders such as dyskeratosis congenita or epidermolysis bullosa. Leukoplakia. Proliferative verrucous leukoplakia. Erythroplakia. Lupus erythematosus. Submucous fibrosis. Hereditary disorders such as dyskeratosis congenita or epidermolysis bullosa. This review classified any level of dysplasia (mild, moderate, or severe) or OSCC as the target conditions.",
        "Reference standards": "Surgical or punch biopsy with histological assessment. Studies not specifying verification by a pathology diagnosis as a reference standard were ineligible for inclusion."
    },
    "search_strategy": {
        "Appendix 1. MEDLINE Ovid search strategy": "1. exp Mouth/2. Cheek/3. or/1\u201024. exp Carcinoma, squamous cell/di5. exp Precancerous conditions/di6. (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$).tw,ot.7. (pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkeratos$).tw,ot.8. or/4\u201079. 3 and 810. exp Mouth neoplasms/di11. Lichen Planus, Oral/di12. Oral submucous fibrosis/di13. Oral candidiasis/di14. ((oral$ or mouth$ or bucca$ or \"oral cavit$\" or (oral adj mucosa$) or (mouth adj mucosa$) or lip or lips or tongue$ or gingiv$ or palat$ or cheek$ or \"intra oral$\" or intraoral$ or gum or gums or labial$) adj3 (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$ or pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkerato$)).tw,ot.15. or/10\u20101416. 9 or 1517. Cytodiagnosis/18. Cytological techniques/19. Cytophotometry/20. (brush adj3 biops$).tw,ot.21. (\"oral cdx\" or oralcdx).tw,ot.22. (\"modified liquid based cytology\" or (exfoliat$ adj3 cytolog$)).tw,ot.23. (brush$ and (cytodiagnosis or cytopathology)).tw,ot.24. Tolonium chloride/25. Coloring agents/du26. (\"tolonium chloride\" or \"tolu?dine blue\" or \"tolu?dine b\" or tblue or t\u2010blue).tw,ot.27. (tolu?dine adj6 (dye$ or rins$ or stain$ or wash$)).tw,ot.28. exp Luminescence/29. Fluorescence/30. Spectrometry, fluorescence/31. exp Luminescent Agents/32. Light/33. Tomography, Optical Coherence/34. (visual$ adj5 (\"light emitting diode\" or \"blue spectrum\" or LED or luminous$)).tw,ot.35. (visuali?ation adj3 adjunct$).tw,ot.36. (vizilite or microlux$ or orascoptic or velscope).tw,ot.37. lumenoscop$.tw,ot.38. ((tumor$ or tumour$ or cancer$ or carcinoma$ or neoplas$ or carcinogen$ or malignan$ or metata$ or lesion$ or ulcer$) adj5 (fluorescen$ or autofluorescen$ or luminescen$ or chemiluminescen$)).tw,ot.39. (tissue adj3 reflect$).tw,ot.40. Spectrophotometry/41. Acetic acid/42. (acetic acid adj3 (wash$ or rins$)).tw,ot.43. acetowhite.tw,ot.44. Saliva/an, ch45. Tumor Markers, Biological/an46. ((\"tumo?r marker$\" or \"neoplas$ marker$\") adj3 (blood or saliva)).tw,ot.47. ((analy$ or screen$ or test$ or examin$) adj3 (blood or saliva)).tw,ot.48. Diagnosis, Oral/49. Mass screening/51. screen$.mp.50. Physical examination/51. ((oral$ or mouth$) adj5 (exam$ or histolog$ or check$ or inspect$)).tw,ot.52. (visual$ adj3 (exam$ or inspect$ or screen$)).tw,ot.53. or/17\u20105254. 16 and 53",
        "Appendix 2. Embase Ovid search strategy": "1. exp Mouth/2. Cheek/3. or/1\u201024. exp Squamous cell carcinoma/di5. exp Precancer/di6. (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$).tw,ot.7. (pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkeratos$).tw,ot.8. or/4\u201079. 3 and 810. exp Mouth tumor/di11. Lichen planus/di12. Thrush/di13. ((oral$ or mouth$ or bucca$ or \"oral cavit$\" or (oral adj mucosa$) or (mouth adj mucosa$) or lip or lips or tongue$ or gingiv$ or palat$ or cheek$ or \"intra oral$\" or intraoral$ or gum or gums or labial$) adj3 (tumor$ or tumour$ or cancer$ or carcinoma$ or carcinogen$ or neoplas$ or malignan$ or metasta$ or dysplas$ or lesion$ or ulcer$ or pre\u2010cancer$ or precancer$ or premalignan$ or precursor$ or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or (actinic adj2 keratosis) or candidiasis or erythroplakia or erythroplas$ or erythroleukoplakia or hyperplas$ or hyperkerato$)).tw,ot.14. or/10\u20101315. 9 or 1416. Cancer cytodiagnosis/17. Cytophotometry/18. (brush adj3 biops$).tw,ot.19. (\"oral cdx\" or oralcdx).tw,ot.20. (\"modified liquid based cytology\" or (exfoliat$ adj3 cytolog$)).tw,ot.21. (brush$ and (cytodiagnosis or cytopathology)).tw,ot.22. Tolonium chloride/23. Coloring agent/24. (\"tolonium chloride\" or \"tolu?dine blue\" or \"tolu?dine b\" or tblue or t\u2010blue).tw,ot.25. (tolu?dine adj6 (dye$ or rins$ or stain$ or wash$)).tw,ot.26. exp Luminescence/27. Fluorescence/28. Spectrofluorometry/29. exp Luminescent Agents/30. Light/31. Tomography, Optical Coherence/32. (visual$ adj5 (\"light emitting diode\" or \"blue spectrum\" or LED or luminous$)).tw,ot.33. (visuali?ation adj3 adjunct$).tw,ot.34. (vizilite or microlux$ or orascoptic or velscope).tw,ot.35. lumenoscop$.tw,ot.36. ((tumor$ or tumour$ or cancer$ or carcinoma$ or neoplas$ or carcinogen$ or malignan$ or metata$ or lesion$ or ulcer$) adj5 (fluorescen$ or autofluorescen$ or luminescen$ or chemiluminescen$)).tw,ot.37. (tissue adj3 reflect$).tw,ot.38. Spectrophotometry/39. Acetic acid/40. (acetic acid adj3 (wash$ or rins$)).tw,ot.41. acetowhite.tw,ot.42. Tumor Marker/43. ((\"tumo?r marker$\" or \"neoplas$ marker$\") adj3 (blood or saliva)).tw,ot.44 ((analy$ or screen$ or test$ or examin$) adj3 (blood or saliva)).tw,ot.45. Mass screening/46. screen$.mp.47. Physical examination/48. ((oral$ or mouth$) adj5 (diagnos$ or exam$ or histolog$ or check$ or inspect$)).tw,ot.49. (visual$ adj3 (exam$ or inspect$ or screen$)).tw,ot.50. or/16\u20104951. 15 and 50",
        "Appendix 3. US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov) search strategy": "Condition: oral cancer Other terms: diagnosis or diagnose Condition: oral cancer Other terms: screen or screening",
        "Appendix 4. World Health Organization International Clinical Trials Registry Platform search strategy": "oral cancer AND diagnosis OR oral cancer AND diagnose OR oral cancer AND diagnostic oral cancer AND screen OR oral cancer AND screening",
        "Appendix 5. Search strategies used in the previous version of this review (April 2013)": "Cochrane Oral Health's Trials Register search strategy An updated search of the Cochrane Oral Health's Trials Register was conducted 30 April 2013 using the Cochrane Register of Studies software and the search strategy below:#1 ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*):ti,ab) AND (INREGISTER)#2 ((tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*):ti,ab) AND (INREGISTER)#3 ((cytodiagnosis or cytophotometry or \"brush biops*\" or \"oral cdx\" or oralcdx or \"modified liquid based cytology\" or \"exfoliat* cytolog*\" or \"tolonium chloride\" or \"toludine b*\" or \"toluidine b*\" or tblue or t\u2010blue or \"toludine dye*\" or \"toludine rins*\" or \"toludine stain*\" or \"toludine wash*\" or \"toluidine dye*\" or \"toluidine rins*\" or \"toluidine stain*\" or \"toluidine wash*\" or luminescence or fluorescen* or \"light emitting diode*\"):ti,ab) AND (INREGISTER)#4 (((blood or saliva) AND (analys* or inspect* or test or examin*)):ti,ab) AND (INREGISTER)#5 ((\"blue spectrum\" or LED or luminous or \"visual* adjunct*\" or vizilite or microlux* or orascoptic or velscope or lumenoscope* or autofluorescen* or chemilumiescen* or spectrophotometr* or \"acetic acid\" or acetowhite or \"tumor marker*\" or \"tumour marker*\" or \"neoplas* marker*\"):ti,ab) AND (INREGISTER)#6 ((diagnos* AND (exam* or histolog* or check* or screen*)):ti,ab) AND (INREGISTER)#7 (#1 and #2) AND (INREGISTER)#8 (#3 or #4 or #5 or #6) AND (INREGISTER)#9 (#7 and #8) AND (INREGISTER)  A previous search was conducted in June 2011 using the Procite software and the search strategies below:((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (cytodiagnosis or cytophotometry or \"brush biops*\" or \"oral cdx\" or oralcdx or \"modified liquid based cytology\" or \"exfoliat* cytolog*\" or \"tolonium chloride\" or \"toludine b*\" or \"toluidine b*\" or tblue or t\u2010blue or \"toludine dye*\" or \"toludine rins*\" or \"toludine stain*\" or \"toludine wash*\" or \"toluidine dye*\" or \"toluidine rins*\" or \"toluidine stain*\" or \"toluidine wash*\" or luminescence or fluorescen* or \"light emitting diode*\"))((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (\"blue spectrum\" or LED or luminous or \"visual* adjunct*\" or vizilite or microlux* or orascoptic or velscope or lumenoscope* or autofluorescen* or chemilumiescen* or spectrophotometr* or \"acetic acid\" or acetowhite or \"tumor marker*\" or \"tumour marker*\" or \"neoplas* marker*\"))((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (diagno* and (blood or saliva) and (analys* or inspect* or test* or examin*)))((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (diagnos* AND (exam* or histolog* or check or inspect* or screen*)))    Cochrane Diagnostic Test Accuracy Register search strategy ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*)    MEDION search strategy Searched using the code C (malignancies), and screened the results for oral cancer terms.",
        "Cochrane Oral Health's Trials Register search strategy": "An updated search of the Cochrane Oral Health's Trials Register was conducted 30 April 2013 using the Cochrane Register of Studies software and the search strategy below:#1 ((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*):ti,ab) AND (INREGISTER)#2 ((tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*):ti,ab) AND (INREGISTER)#3 ((cytodiagnosis or cytophotometry or \"brush biops*\" or \"oral cdx\" or oralcdx or \"modified liquid based cytology\" or \"exfoliat* cytolog*\" or \"tolonium chloride\" or \"toludine b*\" or \"toluidine b*\" or tblue or t\u2010blue or \"toludine dye*\" or \"toludine rins*\" or \"toludine stain*\" or \"toludine wash*\" or \"toluidine dye*\" or \"toluidine rins*\" or \"toluidine stain*\" or \"toluidine wash*\" or luminescence or fluorescen* or \"light emitting diode*\"):ti,ab) AND (INREGISTER)#4 (((blood or saliva) AND (analys* or inspect* or test or examin*)):ti,ab) AND (INREGISTER)#5 ((\"blue spectrum\" or LED or luminous or \"visual* adjunct*\" or vizilite or microlux* or orascoptic or velscope or lumenoscope* or autofluorescen* or chemilumiescen* or spectrophotometr* or \"acetic acid\" or acetowhite or \"tumor marker*\" or \"tumour marker*\" or \"neoplas* marker*\"):ti,ab) AND (INREGISTER)#6 ((diagnos* AND (exam* or histolog* or check* or screen*)):ti,ab) AND (INREGISTER)#7 (#1 and #2) AND (INREGISTER)#8 (#3 or #4 or #5 or #6) AND (INREGISTER)#9 (#7 and #8) AND (INREGISTER)  A previous search was conducted in June 2011 using the Procite software and the search strategies below:((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (cytodiagnosis or cytophotometry or \"brush biops*\" or \"oral cdx\" or oralcdx or \"modified liquid based cytology\" or \"exfoliat* cytolog*\" or \"tolonium chloride\" or \"toludine b*\" or \"toluidine b*\" or tblue or t\u2010blue or \"toludine dye*\" or \"toludine rins*\" or \"toludine stain*\" or \"toludine wash*\" or \"toluidine dye*\" or \"toluidine rins*\" or \"toluidine stain*\" or \"toluidine wash*\" or luminescence or fluorescen* or \"light emitting diode*\"))((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (\"blue spectrum\" or LED or luminous or \"visual* adjunct*\" or vizilite or microlux* or orascoptic or velscope or lumenoscope* or autofluorescen* or chemilumiescen* or spectrophotometr* or \"acetic acid\" or acetowhite or \"tumor marker*\" or \"tumour marker*\" or \"neoplas* marker*\"))((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (diagno* and (blood or saliva) and (analys* or inspect* or test* or examin*)))((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*) AND (diagnos* AND (exam* or histolog* or check or inspect* or screen*)))",
        "Cochrane Diagnostic Test Accuracy Register search strategy": "((oral* or mouth* or bucca* or \"oral cavit*\" or \"oral mucosa\" or \"mouth mucosa\" or lip or lips or tongue* or gingiva* or palat* or cheek* or intra\u2010oral* or intraoral* or gum or gums or labial*) AND (tumour* or tumor* or cancer* or carcinoma* or carcinogen* or neoplas* or malignan* or metasta* or dysplas* or lesion* or ulcer* or precancer* or pre\u2010cancer* or premalignan* or precursor* or \"lichen planus\" or leukoplakia or \"submucous fibrosis\" or \"actinic keratosis\" or candidiasis or erythroplakia or erythroplas* or erythroleukoplakia or hyperplas* or hyperkerato*)",
        "MEDION search strategy": "Searched using the code C (malignancies), and screened the results for oral cancer terms."
    }
}